To request a copy of the full Board Papers for this meeting, please email [email protected]
Membership
- Prof. I Cumming – Non-Executive Director (Chairman) and voting member
- Mr AC Marsh – Chief Executive Officer and voting member
- Prof. A. Hopkins – Non-Executive Director (Deputy Chair) and voting member
- Ms S Banks – Non-Executive Director and voting member
- Ms C Beechey – Director of People and voting member
- Mrs C Eyre – Director of Nursing and voting member
- Mr M Fessal – Non-Executive Director and voting member
- Mr N Henry – Paramedic Practice and Patient Safety Director
- Mr N Hudson – Performance and Improvement Director and voting member
- Mrs J Jasper – Non-Executive Director and voting member
- Mr M Khan – Non-Executive Director and voting member
- Mr V Khashu – Strategy and Engagement Director
- Mr S Nat – Non-Executive Director and voting member
- Mr M MacGregor – Communications Director
- Ms K Rutter – Director of Finance and voting member
- Dr R Steyn – Medical Director and voting member
In attendance
- Ms D Scott – Interim Organisational Assurance Director
- Mr A Brown – CEO Chief of Staff and Head of Enhanced Care
- Ms K Freeman – Private Secretary, Office of the Chief Executive
- Mr P. Higgins – Governance Director and Trust Secretary
- Ms R Farrington – Staff Side Representative
All attendees to this meeting must be aware that access may be given to all minutes and associated documents under the Freedom of Information Act 2000.
Agenda
Item 1
Welcome, apologies and Chairman’s matters – lead by the Chair
Item 2
Declarations of Interest (to enable declarations to be made, of any conflict of interest members may have in relation to any matters contained within the agenda for this meeting) – lead by the Chair
Item 3
Patient Story – lead by the Director of Nursing
Item 4
Any questions from the public relating to matters to be discussed at this Board of Directors meeting – lead by the Chair
Item 5
Board Minutes
Item 5A
- To agree the Minutes of the meetings of the Board of Directors held 18 December 2024 – lead by the Chair (Paper 01)
- To receive and note the response to the question from a member of the public submitted to the meeting of the Board of Directors on 18 December 2024 (Paper 01a)
Item 5B
Board Log and also any matters arising from both sets of Minutes not on the Agenda for this meeting – lead by the Interim Organisational Assurance Director (Paper 02)
Item 6
Board Assurance Framework (BAF) & Review of Risks
To review the Board Assurance Framework and the risk ratings contained therein and to note that a review of the risks contained therein has been undertaken – lead by the Director of Nursing / Head of Risk (Paper 03)
Action – The Board is asked to review and comment on the risks and information included and also endorse the Risk Tolerance Matrix and the revised Risk Tolerance Statement.
Item 7
Chief Executive Officer Reports
Item 7A
To receive the report of the Chief Executive Officer – lead by the CEO (Paper 04)
Action – The Board is asked to review and comment on the risks and information included and also endorse the Risk Tolerance Matrix and the revised Risk Tolerance Statement.
Item 7B
- Executive Scorecard – December 2024 (Paper 05)
- Executive Scorecard ICS Sub Report – December 2024
Action – To receive the Executive Scorecards
Item 7C
Pandemic Plan 2025-2026 for Approval
Action – To receive and approve the Pandemic Plan (Paper 06)
Item 8
Reports of the Director of Finance – lead by the Director of Finance
Item 8A
Month 9 Financial Update (Paper 07)
Action – To receive the report of the Director of Finance
Item 8B
Policy and Procedure Update (Paper 08)
Action – To receive and note the update
Item 9
Report of the Director of People
Item 9A – Board Skills Matrix – lead by the Director of People (Paper 09)
Action – To review and approve the Board Skills Matrix for publication in the Annual Report
Item 10
Combined Clinical Directors Report – lead by the Director of Nursing / The Medical Director / Paramedic Practice and Patient Safety Director (Paper 10)
Action
Receive and note the integrated quality report.
Gain assurance on the quality agenda and the robustness of the quality governance processes that highlight.
Item 11
Service Delivery Report – lead by Director of Performance and Improvement (Paper 11)
Action – To receive the report from the Director of Performance & Improvement on the following:
• Emergency and Urgent operations
• Integrated Emergency and Urgent Care
Item 12
ICS and WMAS Hub Engagement by WMAS Directors – lead by Strategy and Engagement (Paper 12)
Action – To review and approve the ICS and WMAS Engagement links
Item 13
Board Committee Meeting Minutes and Chair’s Reports – Lead by Respective Chairs of Committee (Paper 13 a-e)
Item 13a – Finance and Performance Committee
Action – To receive a verbal report on the meeting of the Finance and Performance Committee held on 28 January 2025. (The Minutes of the meeting held on 29 October 2024 will be submitted if approved at the meeting of the Committee held on 28 January 2025)
Item 13b – Audit Committee
Action – To receive a report from the Chair of the Committee on the meeting of the Committee held on 21 January 2025. To receive the Minutes of the meeting held on 12 November 2024.
Item 13c – People Committee
Action – To receive a report from the Chair of the Committee on the meeting of the Committee held on 11 November 2024.
Item 13d – Quality Governance Committee
Action – To receive a report from the Chair of the Committee on the meeting of the Committee held on 22 January 2025. To receive the Minutes of the meeting held on 22 October 2024.
Item 14
Board of Directors Schedule of Business – lead by Trust Secretary (Paper 14)
To receive the Schedule of Business and Development Sessions
Action –To review and note the Board Schedule of Business
Item 15
Any Other Business – lead by the Chair
Item 16
Date and Time of the next meeting
The next meeting will be on Wednesday 26 March 2025